The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events

<div><p>Epstein-Barr virus (EBV) is a human herpesvirus that causes acute infectious mononucleosis and is associated with cancer and autoimmune disease. While many studies have been performed examining acute disease in adults following primary infection, little is known about the virological and immunological events during EBV’s lengthy 6 week incubation period owing to the challenge of collecting samples from this stage of infection. We conducted a prospective study in college students with special emphasis on frequent screening to capture blood and oral wash samples during the incubation period. Here we describe the viral dissemination and immune response in the 6 weeks prior to onset of acute infectious mononucleosis symptoms. While virus is presumed to be present in the oral cavity from time of transmission, we did not detect viral genomes in the oral wash until one week before symptom onset, at which time viral genomes were present in high copy numbers, suggesting loss of initial viral replication control. In contrast, using a sensitive nested PCR method, we detected viral genomes at low levels in blood about 3 weeks before symptoms. However, high levels of EBV in the blood were only observed close to symptom onset–coincident with or just after increased viral detection in the oral cavity. These data imply that B cells are the major reservoir of virus in the oral cavity prior to infectious mononucleosis. The early presence of viral genomes in the blood, even at low levels, correlated with a striking decrease in the number of circulating plasmacytoid dendritic cells well before symptom onset, which remained depressed throughout convalescence. On the other hand, natural killer cells expanded only after symptom onset. Likewise, CD4+ Foxp3+ regulatory T cells decreased two fold, but only after symptom onset. We observed no substantial virus specific CD8 T cell expansion during the incubation period, although polyclonal CD8 activation was detected in concert with viral genomes increasing in the blood and oral cavity, possibly due to a systemic type I interferon response. This study provides the first description of events during the incubation period of natural EBV infection in humans and definitive data upon which to formulate theories of viral control and disease pathogenesis.</p></div

Plasmacytoid DC declined in the circulation during the incubation period and remained depressed through convalescence.

<p>(A) Representative flow cytometry plots of pDC frequencies amongst non-lymphoid cells (CD3, CD56, CD14, CD20 negative) from samples collected at multiple timepoints for one subject (5524). (B) The percentage of pDC from 5524 over time. (C) Frequencies of pDC over time are shown for all subjects. (D) Frequencies of conventional DC (cDC) (CD11c⁺, HLA-DR⁺ cells) are shown over time for all subjects. (E) Numbers of pDC per mL of whole blood are shown for all subjects. (F) shows the percentage of pDC in samples where viral genomes were detected in the blood by nested PCR (Blood lo) or qPCR (Blood hi). Statistical analysis was performed using a one-way ANOVA with multiple test comparison. Light pink symbols indicate a significant difference (p<0.05) compared to pre-infection; darker pink symbols (p<0.001); red symbols (p<0.0001). Gray symbols indicate no statistical difference.</p

Viral genome detection during the incubation period.

<p>Quantitative viral load was determined by qPCR using DNA from oral wash cell pellets (A) or blood (B). Data are expressed as Log₁₀ viral genome copies/mL of sample. The dashed gray line represents the limit of detection. (C) and (D) show the time to the first positive measurement for each subject for viral genomes detected in the blood (D) by non-quantitative nested PCR (filled squares) or qPCR (filled inverted triangles), or in the oral cavity (C) by nested or qPCR (same results were obtained with both assays) (open circles). The theoretical presence of virus shown in (C) is the estimated time period in which study participants were initially exposed to oral virus. (E) In sequential samples from the incubation period, subjects were scored for which compartment viral genomes were first detected in: blood by nested PCR (blood (lo)), blood by qPCR (blood (hi)), oral, or a simultaneous positive in both compartments. (F) Shows an inset comparing blood and oral cavity for the time period close to symptom onset. The results for twenty-six subjects who had a sample collected within the first two weeks of symptom onset are shown.</p

CD8 T cell activation occurred during the incubation period, although not an EBV specific response.

<p>(A), Time to first response for three distinct immune parameters is shown: CD38 upregulation on total CD8⁺ T cells (filled squares), an increased CD8 to CD4 T cell ratio (open diamonds), or the presence of EBV tetramer binding CD8⁺ T cells above background (0.4%) (filled circles). (B) Frequency of CD8⁺ T cells expressing CD38 over time. (C) Ratio of CD8⁺ to CD4⁺ T cells over time. Statistics were performed using a one-way ANOVA with multiple test comparison. Pink symbols indicate a significant difference (p<0.05) compared to pre-infection. Red symbols indicate a significant difference (p<0.0001) compared to pre-infection. Gray symbols indicate no statistical difference.</p

CD4⁺ Foxp3⁺ T cells transiently decline in the circulation at symptom onset during AIM.

<p>(A) Frequency of Foxp3⁺CD25⁺ cells amongst total CD4⁺ T cells data plotted over time for a representative individual (subject 7112). (B) Normalized frequency of Foxp3⁺ CD4 T cells over time in all subjects. Foxp3⁺ frequencies were normalized to each subject’s pre-infection baseline due to substantial variation in this population between individuals. (C) Number of CD4+ T cells per mL of whole blood over time. Statistics were performed using a one-way ANOVA with multiple test comparison. Gray values are not statistically different. Red value p<0.0001 compared to pre.</p

Gene expression signatures during the incubation period showed distinct kinetic patterns.

<p>43 EBV infection signature genes were measured in total PBMC RNA. Functional categorization of the genes is shown at left. Fold change (FC) in expression was calculated compared to pre-infection samples. Heirarchical clustering (above) showed three distinct groupings: no signature (red), type I IFN (blue), and type II IFN/cell cycle (green). Subject numbers and sample collection date are indicated at top. The presence of viral genomes by nested (lo) or qPCR (hi) is noted below, along with the range of sample days (relative to symptom onset) that each signature was observed in.</p

NKG2A⁺ NK cells were expanded during AIM, but not during the incubation period.

<p>(A) Percentage and number of NK cells that are CD56^bright (immature) decreases during the first 50 days after symptom onset. (B) The percentage and number of NK cells that are CD56^dim NKG2A⁺ KIR^- increases, and remains elevated. Statistics were performed using a one-way ANOVA with multiple test comparison. Pink symbols indicate a significant difference (p<0.05) compared to pre-infection. Red symbols indicate a significant difference (p<0.0001) compared to pre-infection. Gray symbols indicate no statistical difference.</p